Brief: Labcorp Announces Acquisition Of Select Assets Of Bioreference Health's Innovative Oncology And Related Clinical Testing Services Businesses
11/03/2025 11:29
March 11 (Reuters) - Labcorp Holdings Inc LH.N: LABCORP ANNOUNCES ACQUISITION OF SELECT ASSETS OF BIOREFERENCE HEALTH'S INNOVATIVE ONCOLOGY AND RELATED CLINICAL TESTING SERVICES BUSINESSES LABCORP: PURCHASE PRICE FOR TRANSACTION IS UP TO $225 MILLION Source text: ID:nPn4XGDdSa Further company coverage: LH.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Labcorp Holdings
See all newsBrief: Labcorp And Epic Expand Collaboration To Advance Diagnostic Integration Across Hospitals And Health Systems
U.S. STOCKS ON THE MOVE-Quanta, O'Reilly Automotive, Avis
Labcorp lifts full‑year forecast as diagnostics business stays resilient (updated)
U.S. STOCKS ON THE MOVE-Qualcomm, Meta, Cardinal Health
U.S. STOCKS ON THE MOVE-Royal Caribbean, Labcorp, Textron